| 0 |
Guanylate Cyclase-C Agonist [EPC] |
5139 |
2.4766 |
| 1 |
Interleukin-5 Antagonist [EPC] |
1404 |
2.0407 |
| 2 |
Provitamin D2 Compound [EPC] |
27687 |
0.9305 |
| 3 |
Endoglycosidase [EPC] |
909 |
0.4906 |
| 4 |
CD38-directed Cytolytic Antibody [EPC] |
2161 |
0.3692 |
| 5 |
Gamma Secretase Inhibitor [EPC] |
323 |
0.3499 |
| 6 |
Macrolide Antibacterial [EPC] |
354 |
0.3498 |
| 7 |
Ileal Bile Acid Transporter Inhibitor [EPC] |
113 |
0.2484 |
| 8 |
Interleukin-17A Antagonist [EPC] |
8917 |
0.2392 |
| 9 |
Farnesyltransferase Inhibitor [EPC] |
16 |
0.2051 |
| 10 |
Prostacyclin Receptor Agonist [EPC] |
5244 |
0.2009 |
| 11 |
Decorporation Agent [EPC] |
1 |
0.2000 |
| 12 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
1740 |
0.1995 |
| 13 |
Sucrose-specific Enzyme [EPC] |
36 |
0.1989 |
| 14 |
Adrenocorticotropic Hormone [EPC] |
161 |
0.1799 |
| 15 |
Thyroid Hormone Receptor beta Agonist [EPC] |
368 |
0.1601 |
| 16 |
Phosphodiesterase 4 Inhibitor [EPC] |
25491 |
0.1563 |
| 17 |
Nuclear Export Inhibitor [EPC] |
1351 |
0.1542 |
| 18 |
Hemoglobin S Polymerization Inhibitor [EPC] |
3187 |
0.1428 |
| 19 |
Bile Acid Sequestrant [EPC] |
1737 |
0.1420 |
| 20 |
Enzyme Stabilizer [EPC] |
164 |
0.1399 |
| 21 |
Medium-chain Triglyceride [EPC] |
77 |
0.1390 |
| 22 |
Bismuth [EPC] |
771 |
0.1384 |
| 23 |
Melanocortin 4 Receptor Agonist [EPC] |
38 |
0.1333 |
| 24 |
PCSK9 Inhibitor [EPC] |
3413 |
0.1325 |
| 25 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
12757 |
0.1294 |
| 26 |
Integrin Receptor Antagonist [EPC] |
11007 |
0.1264 |
| 27 |
Cortisol Synthesis Inhibitor [EPC] |
94 |
0.1243 |
| 28 |
Bispecific HER2-directed Antibody [EPC] |
10 |
0.1220 |
| 29 |
Human Immunoglobulin G [EPC] |
2561 |
0.1216 |
| 30 |
Blood Viscosity Reducer [EPC] |
522 |
0.1201 |
| 31 |
mu-Opioid Receptor Agonist [EPC] |
348 |
0.1180 |
| 32 |
Prostacycline Vasodilator [EPC] |
15707 |
0.1140 |
| 33 |
Aminosalicylate [EPC] |
11306 |
0.1122 |
| 34 |
Antidiarrheal [EPC] |
26 |
0.1088 |
| 35 |
Phosphate Binder [EPC] |
328 |
0.1077 |
| 36 |
Soluble Guanylate Cyclase Stimulator [EPC] |
3598 |
0.1062 |
| 37 |
Pyrimidine Synthesis Inhibitor [EPC] |
4764 |
0.1056 |
| 38 |
HER2/neu Receptor Antagonist [EPC] |
7898 |
0.1055 |
| 39 |
l-Thyroxine [EPC] |
5 |
0.1020 |
| 40 |
Somatostatin Analog [EPC] |
663 |
0.0965 |
| 41 |
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] |
10 |
0.0962 |
| 42 |
Non-Standardized Fungal Allergenic Extract [EPC] |
205 |
0.0953 |
| 43 |
Alkaloid [EPC] |
2479 |
0.0930 |
| 44 |
Potassium Binder [EPC] |
1377 |
0.0915 |
| 45 |
Antirheumatic Agent [EPC] |
9625 |
0.0910 |
| 46 |
Nucleoside Metabolic Inhibitor [EPC] |
24111 |
0.0880 |
| 47 |
Phenothiazine [EPC] |
2524 |
0.0840 |
| 48 |
Intestinal Lipase Inhibitor [EPC] |
1966 |
0.0836 |
| 49 |
Partial Opioid Agonist/Antagonist [EPC] |
4 |
0.0833 |
| 50 |
Kinase Inhibitor [EPC] |
46391 |
0.0832 |
| 51 |
Iron Chelator [EPC] |
2433 |
0.0831 |
| 52 |
Non-Standardized House Dust Allergenic Extract [EPC] |
61 |
0.0823 |
| 53 |
Amino Acid Hypertonic Solution [EPC] |
13 |
0.0823 |
| 54 |
Peroxisome Proliferator-activated Receptor Agonist [EPC] |
74 |
0.0822 |
| 55 |
Pyridone [EPC] |
3309 |
0.0810 |
| 56 |
beta Lactamase Inhibitor [EPC] |
358 |
0.0805 |
| 57 |
Estrogen Receptor Antagonist [EPC] |
3239 |
0.0799 |
| 58 |
GLP-2 Analog [EPC] |
1061 |
0.0790 |
| 59 |
l-Triiodothyronine [EPC] |
4 |
0.0784 |
| 60 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
462 |
0.0776 |
| 61 |
Serotonin-3 Receptor Antagonist [EPC] |
10526 |
0.0775 |
| 62 |
Cannabinoid [EPC] |
620 |
0.0765 |
| 63 |
Phosphodiesterase 5 Inhibitor [EPC] |
10353 |
0.0765 |
| 64 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
3612 |
0.0764 |
| 65 |
Non-Standardized Insect Allergenic Extract [EPC] |
443 |
0.0762 |
| 66 |
Aluminum Complex [EPC] |
1797 |
0.0743 |
| 67 |
Catecholamine Synthesis Inhibitor [EPC] |
6 |
0.0741 |
| 68 |
Nitrofuran Antibacterial [EPC] |
1301 |
0.0739 |
| 69 |
Nitrogen Binding Agent [EPC] |
178 |
0.0736 |
| 70 |
Interleukin-23 Antagonist [EPC] |
7609 |
0.0727 |
| 71 |
Glucosylceramide Synthase Inhibitor [EPC] |
205 |
0.0725 |
| 72 |
Standardized Insect Venom Allergenic Extract [EPC] |
523 |
0.0722 |
| 73 |
Survival of Motor Neuron 2 Splicing Modifier [EPC] |
300 |
0.0717 |
| 74 |
CTLA-4-directed Blocking Antibody [EPC] |
3452 |
0.0716 |
| 75 |
Histone Deacetylase Inhibitor [EPC] |
271 |
0.0700 |
| 76 |
Pediculicide [EPC] |
328 |
0.0697 |
| 77 |
Calcium [EPC] |
10420 |
0.0696 |
| 78 |
Aromatase Inhibitor [EPC] |
7925 |
0.0696 |
| 79 |
Phosphodiesterase 3 Inhibitor [EPC] |
433 |
0.0695 |
| 80 |
Vasopressin Receptor Agonist [EPC] |
23 |
0.0695 |
| 81 |
Histamine-1 Receptor Antagonist [EPC] |
5855 |
0.0694 |
| 82 |
Non-narcotic Antitussive [EPC] |
1169 |
0.0693 |
| 83 |
Endothelin Receptor Antagonist [EPC] |
13818 |
0.0690 |
| 84 |
Expectorant [EPC] |
14207 |
0.0687 |
| 85 |
Cephalosporin Antibacterial [EPC] |
585 |
0.0682 |
| 86 |
Thalidomide Analog [EPC] |
35568 |
0.0681 |
| 87 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
84 |
0.0677 |
| 88 |
Hematopoietic Stem Cell Mobilizer [EPC] |
100 |
0.0673 |
| 89 |
Non-Standardized Plant Allergenic Extract [EPC] |
1175 |
0.0665 |
| 90 |
Chloride Channel Activator [EPC] |
633 |
0.0662 |
| 91 |
alpha-Hydroxy Acid [EPC] |
142 |
0.0651 |
| 92 |
Nitroimidazole Antimicrobial [EPC] |
4291 |
0.0651 |
| 93 |
Antiparasitic [EPC] |
295 |
0.0650 |
| 94 |
Lymphocyte Growth Factor [EPC] |
82 |
0.0649 |
| 95 |
GLP-1 Receptor Agonist [EPC] |
29087 |
0.0649 |
| 96 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
141 |
0.0647 |
| 97 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
7591 |
0.0644 |
| 98 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
7438 |
0.0643 |
| 99 |
Osmotic Laxative [EPC] |
18950 |
0.0641 |
| 100 |
Standardized Animal Hair Allergenic Extract [EPC] |
55 |
0.0640 |
| 101 |
Urease Inhibitor [EPC] |
3 |
0.0638 |
| 102 |
Antiprotozoal [EPC] |
668 |
0.0628 |
| 103 |
Vitamin C [EPC] |
26025 |
0.0624 |
| 104 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
47 |
0.0623 |
| 105 |
Methylating Agent [EPC] |
65 |
0.0621 |
| 106 |
Benzothiazole [EPC] |
138 |
0.0621 |
| 107 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
2023 |
0.0620 |
| 108 |
Neonatal Fc Receptor Blocker [EPC] |
272 |
0.0620 |
| 109 |
Nucleoside Analog Antiviral [EPC] |
5282 |
0.0618 |
| 110 |
Non-Standardized Food Allergenic Extract [EPC] |
4901 |
0.0613 |
| 111 |
Platinum-based Drug [EPC] |
16722 |
0.0611 |
| 112 |
Microtubule Inhibitor [EPC] |
10117 |
0.0610 |
| 113 |
HMG-CoA Reductase Inhibitor [EPC] |
22639 |
0.0606 |
| 114 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
1561 |
0.0606 |
| 115 |
Interleukin-6 Receptor Antagonist [EPC] |
8375 |
0.0604 |
| 116 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
5815 |
0.0604 |
| 117 |
Tetracycline-class Drug [EPC] |
4246 |
0.0600 |
| 118 |
Bile Acid [EPC] |
1381 |
0.0599 |
| 119 |
Histamine-2 Receptor Antagonist [EPC] |
7876 |
0.0599 |
| 120 |
Vitamin D3 Analog [EPC] |
1212 |
0.0598 |
| 121 |
Vitamin B12 [EPC] |
19206 |
0.0590 |
| 122 |
Non-Standardized Animal Skin Allergenic Extract [EPC] |
1 |
0.0588 |
| 123 |
Proton Pump Inhibitor [EPC] |
34470 |
0.0588 |
| 124 |
Purine Antimetabolite [EPC] |
5806 |
0.0587 |
| 125 |
Non-Standardized Pollen Allergenic Extract [EPC] |
37 |
0.0587 |
| 126 |
Sigma-1 Agonist [EPC] |
513 |
0.0587 |
| 127 |
Vitamin D [EPC] |
17708 |
0.0585 |
| 128 |
Vitamin A [EPC] |
2973 |
0.0584 |
| 129 |
Anticholinergic [EPC] |
948 |
0.0582 |
| 130 |
Macrolide Antimicrobial [EPC] |
3039 |
0.0579 |
| 131 |
Thiazide Diuretic [EPC] |
11972 |
0.0578 |
| 132 |
Antimalarial [EPC] |
605 |
0.0578 |
| 133 |
Standardized Pollen Allergenic Extract [EPC] |
37 |
0.0577 |
| 134 |
Factor Xa Inhibitor [EPC] |
15861 |
0.0576 |
| 135 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
7851 |
0.0575 |
| 136 |
Carnitine Analog [EPC] |
211 |
0.0573 |
| 137 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
3259 |
0.0570 |
| 138 |
Folate Analog [EPC] |
2826 |
0.0568 |
| 139 |
Nicotinic Acid [EPC] |
3488 |
0.0565 |
| 140 |
Sulfonylurea [EPC] |
6928 |
0.0563 |
| 141 |
Interferon alfa-2b [EPC] |
104 |
0.0559 |
| 142 |
Xanthine Oxidase Inhibitor [EPC] |
9677 |
0.0557 |
| 143 |
Thiazide-like Diuretic [EPC] |
2398 |
0.0556 |
| 144 |
Aldosterone Antagonist [EPC] |
8623 |
0.0553 |
| 145 |
Dihydropyridine Calcium Channel Blocker [EPC] |
18137 |
0.0552 |
| 146 |
Vitamin B6 Analog [EPC] |
20 |
0.0551 |
| 147 |
Polymyxin-class Antibacterial [EPC] |
4 |
0.0548 |
| 148 |
Barbiturate [EPC] |
633 |
0.0548 |
| 149 |
Vitamin K [EPC] |
470 |
0.0543 |
| 150 |
Cardiac Glycoside [EPC] |
3896 |
0.0542 |
| 151 |
Proteasome Inhibitor [EPC] |
6185 |
0.0540 |
| 152 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
133 |
0.0539 |
| 153 |
Plasma Kallikrein Inhibitor [EPC] |
129 |
0.0538 |
| 154 |
Polyene Antifungal [EPC] |
2176 |
0.0538 |
| 155 |
Claudin 18.2-directed Cytolytic Antibody [EPC] |
82 |
0.0538 |
| 156 |
Nitrate Vasodilator [EPC] |
4770 |
0.0538 |
| 157 |
Antidote [EPC] |
3396 |
0.0536 |
| 158 |
Potassium-sparing Diuretic [EPC] |
712 |
0.0532 |
| 159 |
Loop Diuretic [EPC] |
24307 |
0.0531 |
| 160 |
alpha-Adrenergic Blocker [EPC] |
7412 |
0.0529 |
| 161 |
Parenteral Iron Replacement [EPC] |
724 |
0.0527 |
| 162 |
beta-Adrenergic Blocker [EPC] |
16028 |
0.0524 |
| 163 |
Cholecystokinin Analog [EPC] |
8 |
0.0523 |
| 164 |
beta3-Adrenergic Agonist [EPC] |
2487 |
0.0521 |
| 165 |
Antimetabolite Immunosuppressant [EPC] |
1110 |
0.0520 |
| 166 |
CD4-directed Blocking Antibody [EPC] |
28 |
0.0519 |
| 167 |
Interleukin-1 Receptor Antagonist [EPC] |
874 |
0.0517 |
| 168 |
Hedgehog Pathway Inhibitor [EPC] |
485 |
0.0516 |
| 169 |
Nonergot Dopamine Agonist [EPC] |
804 |
0.0515 |
| 170 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
20 |
0.0514 |
| 171 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
712 |
0.0513 |
| 172 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
4724 |
0.0512 |
| 173 |
Glinide [EPC] |
451 |
0.0507 |
| 174 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
823 |
0.0505 |
| 175 |
Selective T Cell Costimulation Modulator [EPC] |
7070 |
0.0505 |
| 176 |
Platelet Aggregation Inhibitor [EPC] |
28776 |
0.0503 |
| 177 |
Fluoroquinolone Antibacterial [EPC] |
6521 |
0.0503 |
| 178 |
Corticosteroid [EPC] |
64573 |
0.0502 |
| 179 |
Non-Standardized Animal Hair Allergenic Extract [EPC] |
1 |
0.0500 |
| 180 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
2398 |
0.0499 |
| 181 |
Methylxanthine [EPC] |
2841 |
0.0489 |
| 182 |
Opioid Agonist [EPC] |
13221 |
0.0486 |
| 183 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
52 |
0.0479 |
| 184 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
62152 |
0.0474 |
| 185 |
CD3-directed Antibody [EPC] |
34 |
0.0472 |
| 186 |
Prostaglandin E1 Analog [EPC] |
782 |
0.0471 |
| 187 |
Human alpha-1 Proteinase Inhibitor [EPC] |
200 |
0.0471 |
| 188 |
Calcitonin [EPC] |
146 |
0.0467 |
| 189 |
Interleukin-12 Antagonist [EPC] |
4840 |
0.0466 |
| 190 |
Stimulant Laxative [EPC] |
669 |
0.0465 |
| 191 |
Rifamycin Antibacterial [EPC] |
1683 |
0.0465 |
| 192 |
Leukotriene Receptor Antagonist [EPC] |
1357 |
0.0464 |
| 193 |
Benzodiazepine [EPC] |
31852 |
0.0463 |
| 194 |
Central alpha-2 Adrenergic Agonist [EPC] |
2494 |
0.0462 |
| 195 |
Serotonin Reuptake Inhibitor [EPC] |
4129 |
0.0460 |
| 196 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
5019 |
0.0460 |
| 197 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
2407 |
0.0459 |
| 198 |
Interleukin-17 Receptor A Antagonist [EPC] |
94 |
0.0456 |
| 199 |
Muscle Relaxant [EPC] |
2100 |
0.0454 |
| 200 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1013 |
0.0454 |
| 201 |
Folate Analog Metabolic Inhibitor [EPC] |
19744 |
0.0449 |
| 202 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
151 |
0.0448 |
| 203 |
Anthelmintic [EPC] |
130 |
0.0447 |
| 204 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
231 |
0.0447 |
| 205 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
8238 |
0.0445 |
| 206 |
Cholinergic Muscarinic Antagonist [EPC] |
1726 |
0.0440 |
| 207 |
Sulfonamide Antibacterial [EPC] |
175 |
0.0438 |
| 208 |
Androgen Receptor Inhibitor [EPC] |
3226 |
0.0436 |
| 209 |
Oxaborole Antifungal [EPC] |
3 |
0.0429 |
| 210 |
Tetracycline-class Antibacterial [EPC] |
336 |
0.0427 |
| 211 |
Serotonin-4 Receptor Agonist [EPC] |
28 |
0.0426 |
| 212 |
Azole Antifungal [EPC] |
6617 |
0.0421 |
| 213 |
Complement Factor D Inhibitor [EPC] |
13 |
0.0419 |
| 214 |
Plasma Volume Expander [EPC] |
127 |
0.0410 |
| 215 |
alpha-Glucosidase Inhibitor [EPC] |
198 |
0.0405 |
| 216 |
Ester Local Anesthetic [EPC] |
2015 |
0.0403 |
| 217 |
Antiarrhythmic [EPC] |
4007 |
0.0402 |
| 218 |
Complement 5a Receptor Antagonist [EPC] |
272 |
0.0402 |
| 219 |
Protease Inhibitor [EPC] |
1784 |
0.0401 |
| 220 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
390 |
0.0400 |
| 221 |
Programmed Death Ligand-1 Blocker [EPC] |
863 |
0.0400 |
| 222 |
Vitamin D2 Analog [EPC] |
282 |
0.0395 |
| 223 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
274 |
0.0393 |
| 224 |
Carbonic Anhydrase Inhibitor [EPC] |
795 |
0.0393 |
| 225 |
Sulfone [EPC] |
427 |
0.0392 |
| 226 |
Photoactivated Radical Generator [EPC] |
5 |
0.0391 |
| 227 |
CD20-directed Cytolytic Antibody [EPC] |
12323 |
0.0389 |
| 228 |
Ergot Derivative [EPC] |
191 |
0.0388 |
| 229 |
BCL-2 Inhibitor [EPC] |
2438 |
0.0388 |
| 230 |
Angiotensin 2 Receptor Blocker [EPC] |
12122 |
0.0379 |
| 231 |
Rifamycin Antimycobacterial [EPC] |
132 |
0.0378 |
| 232 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
61 |
0.0377 |
| 233 |
Amide Local Anesthetic [EPC] |
3286 |
0.0377 |
| 234 |
Neurokinin 3 Receptor Antagonist [EPC] |
86 |
0.0374 |
| 235 |
CD30-directed Immunoconjugate [EPC] |
387 |
0.0372 |
| 236 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
47 |
0.0370 |
| 237 |
Progesterone [EPC] |
871 |
0.0367 |
| 238 |
Echinocandin Antifungal [EPC] |
300 |
0.0365 |
| 239 |
Insulin [EPC] |
1693 |
0.0365 |
| 240 |
Lipid Emulsion [EPC] |
96 |
0.0363 |
| 241 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
229 |
0.0362 |
| 242 |
Glycopeptide Antibacterial [EPC] |
2373 |
0.0362 |
| 243 |
Antileishmanial [EPC] |
14 |
0.0361 |
| 244 |
Oxazolidinone Antibacterial [EPC] |
1084 |
0.0358 |
| 245 |
Antihypoglycemic Agent [EPC] |
153 |
0.0357 |
| 246 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
3185 |
0.0356 |
| 247 |
Central Nervous System Stimulant [EPC] |
3101 |
0.0355 |
| 248 |
Janus Kinase Inhibitor [EPC] |
5703 |
0.0355 |
| 249 |
P2Y12 Platelet Inhibitor [EPC] |
4240 |
0.0353 |
| 250 |
Quinolone Antimicrobial [EPC] |
348 |
0.0353 |
| 251 |
Non-Standardized Chemical Allergen [EPC] |
2723 |
0.0352 |
| 252 |
Cholinesterase Inhibitor [EPC] |
671 |
0.0351 |
| 253 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
886 |
0.0351 |
| 254 |
Antimycobacterial [EPC] |
852 |
0.0349 |
| 255 |
Tubulin Inhibiting Agent [EPC] |
10 |
0.0344 |
| 256 |
Penem Antibacterial [EPC] |
1174 |
0.0343 |
| 257 |
CD52-directed Cytolytic Antibody [EPC] |
661 |
0.0341 |
| 258 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
4422 |
0.0339 |
| 259 |
Antifibrinolytic Agent [EPC] |
331 |
0.0336 |
| 260 |
Antiseptic [EPC] |
146 |
0.0334 |
| 261 |
Tricyclic Antidepressant [EPC] |
16 |
0.0334 |
| 262 |
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] |
20 |
0.0332 |
| 263 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
33 |
0.0330 |
| 264 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
442 |
0.0330 |
| 265 |
Cytochrome P450 3A Inhibitor [EPC] |
1995 |
0.0330 |
| 266 |
Adenosine Receptor Agonist [EPC] |
242 |
0.0328 |
| 267 |
Prostacycline [EPC] |
30 |
0.0322 |
| 268 |
Topoisomerase Inhibitor [EPC] |
2464 |
0.0320 |
| 269 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1571 |
0.0320 |
| 270 |
Pyrethroid [EPC] |
56 |
0.0318 |
| 271 |
5-alpha Reductase Inhibitor [EPC] |
3255 |
0.0318 |
| 272 |
Allylamine Antifungal [EPC] |
230 |
0.0317 |
| 273 |
Reducing and Complexing Thiol [EPC] |
79 |
0.0317 |
| 274 |
Alkylating Drug [EPC] |
7731 |
0.0317 |
| 275 |
Catecholamine [EPC] |
2584 |
0.0314 |
| 276 |
Leukocyte Growth Factor [EPC] |
4463 |
0.0313 |
| 277 |
Sympathomimetic-like Agent [EPC] |
1002 |
0.0310 |
| 278 |
Selectin Blocker [EPC] |
43 |
0.0308 |
| 279 |
Complement Inhibitor [EPC] |
1730 |
0.0308 |
| 280 |
Arteriolar Vasodilator [EPC] |
2406 |
0.0306 |
| 281 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
111 |
0.0305 |
| 282 |
Estrogen [EPC] |
5628 |
0.0301 |
| 283 |
Progestin Antagonist [EPC] |
143 |
0.0299 |
| 284 |
Interleukin-36 Receptor Antagonist [EPC] |
12 |
0.0298 |
| 285 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
638 |
0.0298 |
| 286 |
Insulin Analog [EPC] |
13358 |
0.0297 |
| 287 |
Aminoglycoside Antibacterial [EPC] |
1322 |
0.0296 |
| 288 |
Vitamin D Analog [EPC] |
528 |
0.0293 |
| 289 |
5-Lipoxygenase Inhibitor [EPC] |
19 |
0.0292 |
| 290 |
Sodium Channel Blocker [EPC] |
48 |
0.0291 |
| 291 |
Anti-coagulant [EPC] |
107 |
0.0287 |
| 292 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
144 |
0.0286 |
| 293 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
93 |
0.0286 |
| 294 |
CD33-directed Immunoconjugate [EPC] |
104 |
0.0284 |
| 295 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
879 |
0.0283 |
| 296 |
Androgen [EPC] |
774 |
0.0283 |
| 297 |
Photoenhancer [EPC] |
108 |
0.0278 |
| 298 |
Tumor Necrosis Factor Blocker [EPC] |
27646 |
0.0277 |
| 299 |
Human C1 Esterase Inhibitor [EPC] |
106 |
0.0272 |
| 300 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2996 |
0.0272 |
| 301 |
Menin Inhibitor [EPC] |
2 |
0.0270 |
| 302 |
Prostaglandin Analog [EPC] |
2497 |
0.0268 |
| 303 |
Vasopressin V2 Receptor Antagonist [EPC] |
399 |
0.0267 |
| 304 |
RANK Ligand Inhibitor [EPC] |
5445 |
0.0267 |
| 305 |
Anti-epileptic Agent [EPC] |
5874 |
0.0266 |
| 306 |
Melanin Synthesis Inhibitor [EPC] |
30 |
0.0264 |
| 307 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
250 |
0.0257 |
| 308 |
Osmotic Diuretic [EPC] |
134 |
0.0256 |
| 309 |
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] |
49 |
0.0253 |
| 310 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
803 |
0.0251 |
| 311 |
Autologous Cellular Immunotherapy [EPC] |
145 |
0.0250 |
| 312 |
Erythropoiesis-stimulating Agent [EPC] |
1339 |
0.0248 |
| 313 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
594 |
0.0247 |
| 314 |
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] |
56 |
0.0247 |
| 315 |
Estrogen Agonist/Antagonist [EPC] |
64 |
0.0246 |
| 316 |
Lipid-based Polyene Antifungal [EPC] |
315 |
0.0245 |
| 317 |
Mood Stabilizer [EPC] |
5343 |
0.0243 |
| 318 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
683 |
0.0242 |
| 319 |
Pyruvate Kinase Activator [EPC] |
32 |
0.0240 |
| 320 |
Leptin Analog [EPC] |
30 |
0.0238 |
| 321 |
Parathyroid Hormone Analog [EPC] |
2652 |
0.0236 |
| 322 |
Potassium Channel Blocker [EPC] |
1687 |
0.0236 |
| 323 |
Chemokine Receptor Type 4 Interaction [EPC] |
32 |
0.0235 |
| 324 |
Monobactam Antibacterial [EPC] |
64 |
0.0235 |
| 325 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
12 |
0.0233 |
| 326 |
Nucleoside Analog Antifungal [EPC] |
33 |
0.0233 |
| 327 |
Typical Antipsychotic [EPC] |
582 |
0.0232 |
| 328 |
Thyroid Stimulating Hormone [EPC] |
24 |
0.0231 |
| 329 |
Anti-IgE [EPC] |
2010 |
0.0231 |
| 330 |
Actinomycin [EPC] |
49 |
0.0222 |
| 331 |
CD22-directed Immunoconjugate [EPC] |
66 |
0.0221 |
| 332 |
Melatonin Receptor Agonist [EPC] |
288 |
0.0217 |
| 333 |
Selective T Cell Costimulation Blocker [EPC] |
101 |
0.0213 |
| 334 |
Atypical Antipsychotic [EPC] |
9475 |
0.0210 |
| 335 |
Tyrosine Kinase 2 Inhibitor [EPC] |
62 |
0.0208 |
| 336 |
Opioid Antagonist [EPC] |
20 |
0.0208 |
| 337 |
Interferon gamma [EPC] |
29 |
0.0206 |
| 338 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
149 |
0.0204 |
| 339 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
23 |
0.0203 |
| 340 |
Cholinergic Muscarinic Agonist [EPC] |
56 |
0.0202 |
| 341 |
Neuraminidase Inhibitor [EPC] |
51 |
0.0202 |
| 342 |
Sclerosing Agent [EPC] |
9 |
0.0200 |
| 343 |
Thrombopoietin Receptor Agonist [EPC] |
303 |
0.0200 |
| 344 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
68 |
0.0199 |
| 345 |
Orexin Receptor Antagonist [EPC] |
370 |
0.0199 |
| 346 |
Type I Interferon Receptor Antagonist [EPC] |
38 |
0.0198 |
| 347 |
alpha-1 Adrenergic Agonist [EPC] |
87 |
0.0196 |
| 348 |
Erythroid Maturation Agent [EPC] |
51 |
0.0195 |
| 349 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
268 |
0.0193 |
| 350 |
APOC-III-directed RNA Interaction [EPC] |
2 |
0.0192 |
| 351 |
Anti-anginal [EPC] |
202 |
0.0192 |
| 352 |
Asparagine-specific Enzyme [EPC] |
258 |
0.0191 |
| 353 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
331 |
0.0191 |
| 354 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
147 |
0.0190 |
| 355 |
Classical Complement Pathway Inhibitor [EPC] |
6 |
0.0187 |
| 356 |
Anthracycline Topoisomerase Inhibitor [EPC] |
45 |
0.0185 |
| 357 |
Interleukin-6 Antagonist [EPC] |
12 |
0.0185 |
| 358 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
354 |
0.0180 |
| 359 |
Dopamine and Norepinephrine Reuptake Inhibitor [EPC] |
69 |
0.0179 |
| 360 |
Aromatic Amino Acid [EPC] |
1053 |
0.0174 |
| 361 |
Partial Opioid Agonist [EPC] |
1625 |
0.0173 |
| 362 |
Phenylalanine Metabolizing Enzyme [EPC] |
146 |
0.0171 |
| 363 |
Influenza A M2 Protein Inhibitor [EPC] |
269 |
0.0171 |
| 364 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
14 |
0.0170 |
| 365 |
Cholinergic Nicotinic Agonist [EPC] |
1014 |
0.0166 |
| 366 |
Complement C5 Inhibitor [EPC] |
2 |
0.0165 |
| 367 |
Amyloid Beta-directed Antibody [EPC] |
63 |
0.0164 |
| 368 |
Lysosomal beta Glucuronidase [EPC] |
1 |
0.0156 |
| 369 |
CCR5 Co-receptor Antagonist [EPC] |
35 |
0.0153 |
| 370 |
CD19-directed Cytolytic Antibody [EPC] |
13 |
0.0152 |
| 371 |
Dopamine-2 Receptor Antagonist [EPC] |
117 |
0.0150 |
| 372 |
Acetylcholine Release Inhibitor [EPC] |
1486 |
0.0150 |
| 373 |
Interferon beta [EPC] |
2833 |
0.0147 |
| 374 |
Cardiac Myosin Inhibitor [EPC] |
87 |
0.0144 |
| 375 |
Diagnostic Dye [EPC] |
9 |
0.0139 |
| 376 |
Gonadotropin [EPC] |
30 |
0.0137 |
| 377 |
Lipopeptide Antibacterial [EPC] |
128 |
0.0135 |
| 378 |
Human Blood Coagulation Factor [EPC] |
11 |
0.0134 |
| 379 |
Uric Acid-specific Enzyme [EPC] |
51 |
0.0132 |
| 380 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
52 |
0.0129 |
| 381 |
Gadolinium-based Contrast Agent [EPC] |
62 |
0.0126 |
| 382 |
Small Interfering RNA [EPC] |
2 |
0.0125 |
| 383 |
Radiographic Contrast Agent [EPC] |
316 |
0.0122 |
| 384 |
CD19-directed Chimeric Antigen Receptor [EPC] |
124 |
0.0122 |
| 385 |
Polyene Antimicrobial [EPC] |
5 |
0.0122 |
| 386 |
Aryl Hydrocarbon Receptor Agonist [EPC] |
24 |
0.0122 |
| 387 |
Lead Chelator [EPC] |
1 |
0.0119 |
| 388 |
Copper-containing Intrauterine Device [EPC] |
580 |
0.0117 |
| 389 |
Benzodiazepine Antagonist [EPC] |
10 |
0.0113 |
| 390 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
116 |
0.0112 |
| 391 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
20 |
0.0112 |
| 392 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
20 |
0.0112 |
| 393 |
Radioactive Diagnostic Agent [EPC] |
34 |
0.0108 |
| 394 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
175 |
0.0106 |
| 395 |
Semifluorinated Alkane [EPC] |
24 |
0.0103 |
| 396 |
Oxytocic [EPC] |
31 |
0.0102 |
| 397 |
Recombinant Human Growth Hormone [EPC] |
223 |
0.0101 |
| 398 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
211 |
0.0101 |
| 399 |
Paramagnetic Contrast Agent [EPC] |
45 |
0.0098 |
| 400 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
4992 |
0.0096 |
| 401 |
Interleukin-13 Antagonist [EPC] |
64 |
0.0095 |
| 402 |
Antisense Oligonucleotide [EPC] |
114 |
0.0095 |
| 403 |
Monoamine Oxidase Inhibitor [EPC] |
29 |
0.0094 |
| 404 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
62 |
0.0089 |
| 405 |
General Anesthetic [EPC] |
364 |
0.0083 |
| 406 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
77 |
0.0079 |
| 407 |
Protease Activator [EPC] |
1 |
0.0078 |
| 408 |
Skin Test Antigen [EPC] |
14 |
0.0074 |
| 409 |
Progestin [EPC] |
2131 |
0.0073 |
| 410 |
Vasoconstrictor [EPC] |
2 |
0.0067 |
| 411 |
Human Antihemophilic Factor [EPC] |
1 |
0.0065 |
| 412 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
84 |
0.0063 |
| 413 |
Retinoid [EPC] |
1406 |
0.0057 |
| 414 |
Interleukin-31 Receptor alpha Antagonist [EPC] |
89 |
0.0056 |
| 415 |
CD123 Interaction [EPC] |
3 |
0.0056 |
| 416 |
Contrast Agent for Ultrasound Imaging [EPC] |
31 |
0.0053 |
| 417 |
Radioligand Therapeutic Agent [EPC] |
65 |
0.0047 |
| 418 |
Recombinant Human Nerve Growth Factor [EPC] |
49 |
0.0036 |
| 419 |
Ectoparasiticide [EPC] |
14 |
0.0036 |
| 420 |
Cytolytic Agent [EPC] |
8 |
0.0034 |
| 421 |
Humanized Monoclonal Antibody Fragment [EPC] |
4 |
0.0028 |
| 422 |
TRPM8 Thermoreceptor Agonist [EPC] |
8 |
0.0013 |